ofloxacin has been researched along with Enlarged Spleen in 3 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In tests with 18 drug-susceptible strains of Mycobacterium tuberculosis, the MIC at which 50% of the strains are inhibited by levofloxacin (LVFX) was one dilution less than that at which 50% of the strains are inhibited by ofloxacin (OFLO), but the MICs at which 90% of the strains are inhibited were similar." | 7.69 | In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis. ( Grosset, J; JI, B; Lounis, N; Truffot-Pernot, C, 1995) |
| "In tests with 18 drug-susceptible strains of Mycobacterium tuberculosis, the MIC at which 50% of the strains are inhibited by levofloxacin (LVFX) was one dilution less than that at which 50% of the strains are inhibited by ofloxacin (OFLO), but the MICs at which 90% of the strains are inhibited were similar." | 3.69 | In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis. ( Grosset, J; JI, B; Lounis, N; Truffot-Pernot, C, 1995) |
| "To describe a case of virus-associated hemophagocytic syndrome with ocular changes resembling Vogt-Koyanagi-Harada disease prior to the systemic changes." | 1.38 | Ocular findings in a patient with virus-associated hemophagocytic syndrome. ( Cheng, Y; Ding, W; Liu, Y; Xu, Y; Yao, H, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yao, H | 1 |
| Liu, Y | 1 |
| Ding, W | 1 |
| Xu, Y | 1 |
| Cheng, Y | 1 |
| Hobeika, EM | 1 |
| Usta, IM | 1 |
| Taher, AT | 1 |
| Nassar, AH | 1 |
| JI, B | 1 |
| Lounis, N | 1 |
| Truffot-Pernot, C | 1 |
| Grosset, J | 1 |
1 review available for ofloxacin and Enlarged Spleen
| Article | Year |
|---|---|
Splenomegaly, pancytopenia and pregnancy: a case report and review of the literature.
Topics: Adult; Anti-Bacterial Agents; Blood Transfusion; Diagnostic Errors; Female; Glucocorticoids; Hepatom | 2005 |
2 other studies available for ofloxacin and Enlarged Spleen
| Article | Year |
|---|---|
Ocular findings in a patient with virus-associated hemophagocytic syndrome.
Topics: Antiviral Agents; Cytomegalovirus Infections; Dexamethasone; Drug Therapy, Combination; Fatal Outcom | 2012 |
In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Dose-Response Relationship, Drug; Female; Flu | 1995 |